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Palliative radiotherapy
Calculus of reirradiation in in-ﬁeld metastatic recurrences of spinal cord
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Introduction. The incidence of recurrence in patients with spinal cord metastases ranges from 2.5% to 11% within two and forty
moths after the ﬁrst course of radiotherapy. In most of the cases radiotherapy is the only treatment, but this is not free of
complications. This problem arises depending on the BED administrated and accumulated in spinal cord. The purpose of this
study is to explain the case of the ﬁrst patient treated in our hospital with a second re-irradiation in spinal cord.
Material and methods. A case of a patient with ductal carcinoma of the right breast pT2N3aM0 diagnosed in 2003 is analysed.
In November 2010 she described pelvic paresthesias + miccional/anal incontinency by metastatic cord injury and a palliative
treatment with radiotherapy in D12-L2 (30Gy) was administrated. She was reirradiated in June 2011 by clinical progression (20Gy,
5 × 4Gy). In treatment with Tyverb+ Trastuzumab she marked deterioration in clinic with a progression of her disease.
Results. First and second BED was calculated as follow: 10 fractions × 3Gy (1 + 3/4) = 52.5Gy+5 fractions × 4Gy (1 + 4/4), with a /
of 4, because the lesion was at the lumbar cord. A course of 10 fractions × 2Gy (1 + 2/4) = 30Gy was given at the affected area
exclusively with a daily cone beam. In order to calculate the adequate dose and fractionation in this case, it was taken into
account the low incidence of lumbar myelitis with a BED≤135.5Gy, a period >6 months and a BED in each course ≤98Gy.
Conclusions. Many patients previously irradiated with spinal cord metastases may develop an in-ﬁeld recurrence again. Therefore,
it is necessary / and the technological to know the tolerated maximal dose, the speciﬁc possibilities of every machine and
every Radiation Oncology Department.
http://dx.doi.org/10.1016/j.rpor.2013.03.404
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Introduction. Opioids are the most potent analgesics to control cancer pain, but its use is associated with onset of gastrointestinal
disorders. Constipation affects up to 90% of patients treated with opioides affecting their quality of life, which may result in the
discontinuation of treatment. The combination of oxycodone (higher opioid analgesic) and naloxone (antagonist opioid recep-
tors), in extended release oral formulation, provides an effective analgesic comparable to oxycodone alone, and also signiﬁcantly
counteracts the opioid-induced constipation.
Objectives. Determine the effectiveness of the oxycodone/naloxone in controlling bone pain caused by metastasis, and the
incidence of constipation associated with the intake of these.
Method. Pilot observational study of patients with pain due to bone metastasis who went in for consults to the Oncology Radiation
unit of the Complexo Hospitalario Universitario Ourense. Effectiveness of the medication was assessed by visual analog scale
pain (EVA), and sleep with a scale of 0 (Normal) to 10 (not sleeping), and the performance status of the patient with scale 0
(unaffected) up to 10 (bedridden); during the initial consultation, 1 month, 3 months. Adverse reactions to treatment were also
evaluated (nausea, vomiting, constipation with laxatives, constipation without laxatives, drowsiness, dry mouth, headache,
confusion, dizziness, pruritus, fatigue, hallucinations (G1:mild, G2:moderate, G3:intense, G4:life threatening). Wilcoxon test was
used to analyze ordinal qualitative variables.
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Results. 21 patients, mean age 74, 81 years (DS±6,377), 85.7% male, the most common primary tumor were prostate (42.9%),
followed by lung (33.3%). All received radiation therapy (20–30Gy), located metastatic bone pain: column (47.6%), pelvis (28.6%)
and rib (23.8%). On ﬁrst visit the most frequent score for pain was EVA 8 (42.9%), for sleep 7 (33.3%), and for status performance 6
(38.1%). There was signiﬁcant improvement of pain (1%) during ﬁrst month and 3 months of treatment. Only 3 patients presented
constipation at 3 months.
Conclusions. There was an adequate control of pain with low rate of constipation.
http://dx.doi.org/10.1016/j.rpor.2013.03.405
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Background. Although computed tomography and magnetic resonance imaging have greatly contributed to the ability to identify
metastatic disease in head and neck cancer, inadequacies in evaluating lymphadenopathy still exist. Case description: Here
we present a patient with neck pain of about 3 months of progression. Over time the pain was becoming more intense. This
symptomatology following a cervical MRI study was attributed to a cervical discopathy, for this reason the patient was referred
to our outpatient clinic, and on physical examination shows no neurological deﬁcit, only there is a tenderness in the back of the
neck. However, in the cervical MRI we observed the presence of a small mass that enhanced the contrast material in the posterior
subaponeurotic tissue of the cervical region. To our view, this mass was consistent with a metastatic tumor lesion, so surgery
was recommended. Radical excision was performed, and the pathological study conﬁrmed that the lesion was compatible with
soft tissue metastases of adenocarcinoma originating in the lung. Afterwards the patient received chemo- and radiation therapy.
Conclusions. Don et al. (1995), in 36 neck dissections from patients with squamous cell cancer found a large number of malignant
nodes having diameters of less than 10mm. Since the current radiological criteria for assessing the status of the cervical lymph
nodes are based largely on size, the ﬁndings indicate the major limitations in the detection capabilities of metastatic disease.
For this reason it is important the history, the physical examination and a detailed analysis of imaging studies. Because, of this
depends that patients receive an adequate treatment for their condition and needs.
http://dx.doi.org/10.1016/j.rpor.2013.03.406
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Background. Continuous, hyperfractionated, accelerated radiotherapy schedule is based on a dual premise, aggressive shortening
of the overall treatment time and a reduction in the radiation dose per fraction, increase the tumoricidal effect and tolerance of
late adverse events. This schedule of alterated fractionation, would offer a therapeutic advantage by delivering a high BED in a
reduced treatment time in radiotherapy of symptomatic bulky cervical nodes in terminal patients with a short vital prognosis,
where late effects are not signiﬁcant.
Purpose. To test the safety and affectivity of hyperfractionated-accelerated radiotherapy (HART) in patients with symptomatic
bulky cervical nodes and poor vital prognosis.
Methods and materials. 6 patients were treated in 2012, 5 men and 1 woman, average age 65 years and median Karnofsky score,
80% with neck nodes bigger than 6 cm in. Primary sites were lung in 4 patients and head and neck in 2. The mean total dose
was 53Gy, median dose per fraction 2Gy twice a day and average treatment time of 11 days. CTV encompassed GTV plus 1 cm
margin.
Results. All patients present signs of skin tumor inﬁltration and 5 patients has also pain with inadequate analgesic control with
opioid. Radiotherapy was administrated to relive pain and to prevent skin infection, ulceration and psychological impact. Visual
analog scale score (VAS) was >7 in all patients before radiotherapy, with a reduction of 6 or more points in VAS scores 1 week
after treatment in all. CT Scans performed 1 month after, showed a tumor volume shrinkage >85% in 5 patients. Average survival
time was 3 months, and no skin ulceration or infection was seen. No GIII-IV skin or mucous membrane reaction was seen.
Conclusion. HART could be a good option of palliative symptomatic treatment for poor prognosis patients with bulky neck nodes
where high radiation doses are needed in a short time.
http://dx.doi.org/10.1016/j.rpor.2013.03.407
